Insights

NAD+ Leader ChromaDex, now Niagen Bioscience, is a recognized global authority on NAD+ with a robust research footprint, suggesting strong credibility and potential for partnerships in clinical science, nutraceuticals, and pharmaceutical-grade NAD+ applications.

Product Depth Two main product lines exist: Tru Niagen dietary supplement and Niagen Plus pharmaceutical-grade therapies, indicating cross-market expansion opportunities from consumer wellness to clinic-based treatments.

Strategic Rebranding Recent name change to Niagen Bioscience and strategic refocusing on NAD+ science, signaling openness to new collaborations, licensing deals, and research partnerships under a unified scientific brand.

Recent Divestiture Sale of the ChromaDex Reference Standards business to LGC to streamline operations, freeing resources for core NAD+ science and potential partnerships in high-value research and development initiatives.

Financial and Expansion Signals Revenue scale and investor activity, combined with ongoing leadership engagement and public disclosures, point to opportunities in strategic partnerships, co-development agreements, and large-scale distribution channels for NAD+ products.

ChromaDex Tech Stack

ChromaDex uses 8 technology products and services including Google Analytics 4, AWS Glue, Microsoft Excel, and more. Explore ChromaDex's tech stack below.

  • Google Analytics 4
    Analytics
  • AWS Glue
    Big Data Processing
  • Microsoft Excel
    Editors
  • OneDrive
    File Sharing
  • Klaviyo
    Marketing Automation
  • Microsoft
    Miscellaneous
  • Google Tag Manager
    Tag Management
  • Zoom
    Web Conferencing

Media & News

ChromaDex's Email Address Formats

ChromaDex uses at least 2 format(s):
ChromaDex Email FormatsExamplePercentage
FirstL@chromadex.comJohnD@chromadex.com
44%
First.Last@chromadex.comJohn.Doe@chromadex.com
41%
FirstLast@chromadex.comJohnDoe@chromadex.com
10%
Last@chromadex.comDoe@chromadex.com
5%

Frequently Asked Questions

What is ChromaDex's phone number?

Minus sign iconPlus sign icon
You can contact ChromaDex's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ChromaDex's stock symbol?

Minus sign iconPlus sign icon
ChromaDex is a publicly traded company; the company's stock symbol is CDXC.

What is ChromaDex's official website and social media links?

Minus sign iconPlus sign icon
ChromaDex's official website is niagenbioscience.com and has social profiles on LinkedInCrunchbase.

What is ChromaDex's SIC code NAICS code?

Minus sign iconPlus sign icon
ChromaDex's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 71394 - Fitness and Recreational Sports Centers.

How many employees does ChromaDex have currently?

Minus sign iconPlus sign icon
As of July 2026, ChromaDex has approximately 143 employees across 5 continents, including North AmericaAfricaAsia. Key team members include Chief Scientific Officer: J. D. M.Chief Financial Officer (cfo): N. P.Vice President Business Development: G. S.. Explore ChromaDex's employee directory with LeadIQ.

What industry does ChromaDex belong to?

Minus sign iconPlus sign icon
ChromaDex operates in the Wellness and Fitness Services industry.

What technology does ChromaDex use?

Minus sign iconPlus sign icon
ChromaDex's tech stack includes Google Analytics 4AWS GlueMicrosoft ExcelOneDriveKlaviyoMicrosoftGoogle Tag ManagerZoom.

What is ChromaDex's email format?

Minus sign iconPlus sign icon
ChromaDex's email format typically follows the pattern of FirstL@chromadex.com. Find more ChromaDex email formats with LeadIQ.

How much funding has ChromaDex raised to date?

Minus sign iconPlus sign icon
As of July 2026, ChromaDex has raised $85M in funding. The last funding round occurred on Oct 14, 2022 for $3.1M.

When was ChromaDex founded?

Minus sign iconPlus sign icon
ChromaDex was founded in 1999.
ChromaDex logo

ChromaDex

Wellness and Fitness ServicesCalifornia, United States51-200 Employees

Niagen Bioscience, Inc., based in Irvine, California, focuses on the science of nicotinamide adenine dinucleotide (NAD+) and its role in healthy aging. It is described as a global authority on NAD+ and collaborates with independent researchers worldwide to explore the potential of this coenzyme, which declines with age and stress. The organization backs its patented nicotinamide riboside (Niagen) with a broad body of human clinical trials and peer‑reviewed studies, emphasizing safety, quality, and transparency. It was founded in 1999 and was formerly known as ChromaDex.

Niagen Bioscience offers two product lines: Tru Niagen, a consumer-oriented supplement designed to raise NAD+ levels, and Niagen Plus, a pharmaceutical-grade NAD+ therapy available by prescription at clinics. Its customer base includes individuals pursuing healthy aging and clinics that administer Niagen Plus; the company maintains operations in Irvine and other California sites in Tustin and Westwood, along with a research Laboratory & Innovation Center in Longmont, Colorado.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CDXC
NAICS Code
71394 - Fitness and Recreational Sports Centers
Founded
1999
Employees
51-200

Section iconFunding & Financials

  • $85M

    ChromaDex has raised a total of $85M of funding over 13 rounds. Their latest funding round was raised on Oct 14, 2022 in the amount of $3.1Mas a post_ipo_equity.

  • $50M$100M

    ChromaDex's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $85M

    ChromaDex has raised a total of $85M of funding over 13 rounds. Their latest funding round was raised on Oct 14, 2022 in the amount of $3.1Mas a post_ipo_equity.

  • $50M$100M

    ChromaDex's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.